Omalizumab for chronic urticaria

20th July 2015 by Louise Hudman

Omalizumab for chronic urticaria

This is a new guideline from Nice recommending that omalizumab can be considered in chronic urticaria.

Apparently it is already being used on occasion, though due to cost, it is more common for immunosuppressants like ciclosporin to be used. Omalizumab is preferred because of less need for monitoring.

It is not disease modifying and repeat courses are likely to be required.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I’m loving LocumDeck, it’s a great piece of software."

Dr David Williams, GP, Wales

Dr David Williams, GP, Wales

See the full list of features within our NASGP membership plans

Membership